| 1 | Microglial-Mediated Tau Clearance Dysfunction via TREM2 Receptor Impairment h-var-59fc393ba6 | MAPT | proposed | 0.937 | 2026-05-13 | Open → |
| 2 | Glymphatic-Mediated Tau Clearance Dysfunction h-var-95b0f9a6bc | MAPT | validated | 0.865 | 2026-05-16 | Open → |
| 3 | MAPT tau seeding and release across AD, FTD, and PD-spectrum disease h-cross-synth-mapt-tau-seeding | MAPT | validated | 0.812 | 2026-05-14 | Open → |
| 4 | Dual-Circuit Tau Vulnerability Cascade h-var-8412ce00a4 | MAPT | promoted | 0.774 | 2026-05-16 | Open → |
| 5 | Cholinergic Basal Forebrain-Hippocampal Circuit Protection h-var-f687d4593b | MAPT | promoted | 0.760 | 2026-05-13 | Open → |
| 6 | Repeat-domain exposure defines seed-competent tau conformers h-3ab2bff6a46b | MAPT | proposed | 0.760 | 2026-05-14 | Open → |
| 7 | Dopaminergic Ventral Tegmental-Hippocampal Circuit Protection h-var-bc4357c8c5 | MAPT | proposed | 0.751 | 2026-05-13 | Open → |
| 8 | Tau/MAP6 ratio as a master switch for microtubule dynamics plasticity h-c704dd991041 | MAPT | proposed | 0.750 | 2026-05-16 | Open → |
| 9 | Tau dysfunction destabilizes labile pool h-e3557d75fa56 | MAPT | proposed | 0.750 | 2026-05-14 | Open → |
| 10 | Tau missorting transitions into an autonomous tau-seeding state after transient… h-cb692686e2 | MAPT | proposed | 0.740 | 2026-05-14 | Open → |
| 11 | A tau PTM barcode gates trans-synaptic templating h-fde8ac75360e | MAPT | proposed | 0.738 | 2026-05-14 | Open → |
| 12 | Microglial TREM2-Mediated Tau Phagocytosis Impairment h-var-69c66a84b3 | MAPT | proposed | 0.676 | 2026-05-13 | Open → |
| 13 | Selective Tau Kinase Inhibition in Vulnerable Neuronal Subtypes h-3fdee932 | MAPT | proposed | 0.676 | 2026-05-14 | Open → |
| 14 | Locus Coeruleus-Hippocampal Circuit Protection h-23b94ed8 | MAPT | promoted | 0.668 | 2026-05-16 | Open → |
| 15 | Glymphatic-Cholinergic Tau Clearance Cascade h-var-6a0893ffb6 | MAPT | proposed | 0.666 | 2026-05-16 | Open → |
| 16 | Excitatory Neuron Synaptic Dysfunction and Mitochondrial Stress via MAPT (tau) h-ea85fbfb90 | MAPT | proposed | 0.660 | 2026-05-16 | Open → |
| 17 | Competition-based domain allocation h-5bdd4e163c5a | MAPT | proposed | 0.650 | 2026-05-14 | Open → |
| 18 | Rutin stabilizes a non-nucleating tau conformer through direct MAPT repeat-doma… h-1e70cd6400 | MAPT | proposed | 0.627 | 2026-05-14 | Open → |
| 19 | Tau Cross-Seeding and Interaction h-c157796b69 | MAPT | proposed | 0.610 | 2026-05-14 | Open → |
| 20 | Rutin reduces ROS- and metal-driven tau oligomer nucleation h-86d0aa1ede | MAPT | proposed | 0.602 | 2026-05-14 | Open → |
| 21 | Dual-Circuit Tau Vulnerability Cascade with Glial-Mediated Amplification h-var-1906e102cf | MAPT | proposed | 0.568 | 2026-05-13 | Open → |
| 22 | Developmental stage-specific dominance of tau vs MAP6 function h-86101c8cd6ec | MAPT | proposed | 0.550 | 2026-05-16 | Open → |
| 23 | Microglial Exosome-Mediated Tau Propagation h-var-93e3ef09b3 | MAPT | proposed | 0.539 | 2026-05-13 | Open → |
| 24 | Glymphatic-Mediated Tau Clearance Dysfunction (Proteomics DE) h-var-95b0f9a6bc-pro | MAPT | proposed | 0.500 | 2026-05-16 | Open → |
| 25 | Tau Conformational Change-Triggered Membrane Disruption hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-1 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 26 | Vesicle Size-Selective Nanobody Penetration hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-7 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 27 | pH-Activated Membrane Fusion Nanobodies hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-2 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 28 | Phosphatidylserine-Targeting Nanobody Chimeras hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-3 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 29 | ATP Depletion-Responsive Penetrating Nanobodies hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-6 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 30 | Competitive Glycan Decoys for Tau Vesicle Neutralization hyp-SDA-2026-04-09-gap-debate-20260409-201742-d279750b-6 | MAPT | active | 0.455 | 2026-05-13 | Open → |
| 31 | Cholesterol Depletion-Targeting Nanobody Vectors hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-4 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 32 | Membrane Curvature-Responsive Cell-Penetrating Nanobodies hyp-SDA-2026-04-09-gap-debate-20260409-201742-ca7016f1-5 | MAPT | active | 0.455 | 2026-05-16 | Open → |
| 33 | Combinatorial PTM signatures distinguish pathological from physiological tau st… hyp-SDA-2026-04-09-gap-debate-20260409-201742-1e8eb3bd-3 | MAPT | active | 0.455 | 2026-05-13 | Open → |
| 34 | Dopaminergic Ventral Tegmental-Striatal Circuit Protection h-var-10237959a6 | MAPT | promoted | 0.380 | 2026-05-13 | Open → |
| 35 | Epigenetic Age Acceleration Moderates the Amyloid-to-Tau Conversion Cascade — A… 7 ev h-59d95760 | MAPT | active | 0.343 | 2026-05-14 | Open → |
| 36 | Tau Post-Translational Modification State Targeting h-debate-16810224092e | MAPT | proposed | 0.000 | 2026-05-14 | Open → |
| 37 | Neuronal MAPT-Vulnerability Stratified Therapy h-debate-f3f40ca6614b | MAPT | proposed | 0.000 | 2026-05-14 | Open → |
| 38 | Vesicle Surface Glycan Pattern Recognition h-debate-c4385a075deb | MAPT | proposed | 0.000 | 2026-05-14 | Open → |
| 39 | pH-Sensitive Tau Vesicle Targeting h-debate-329991626a91 | MAPT | proposed | 0.000 | 2026-05-14 | Open → |
| 40 | MAPT Transcriptional Control h-debate-ce7761a039f7 | MAPT | proposed | 0.000 | 2026-05-14 | Open → |
| 41 | IDR Competition Therapy h-debate-fbca3a2cb8ee | MAPT | proposed | 0.000 | 2026-05-14 | Open → |
| 42 | Tau-Induced Lipid Membrane Asymmetry Exploitation h-debate-810c1e5a5acc | MAPT | proposed | 0.000 | 2026-05-14 | Open → |
| 43 | Tau Conformational State-Specific Nanobody Targeting h-debate-f7e4ecbf7b3a | MAPT | proposed | 0.000 | 2026-05-14 | Open → |